15% OFF YOUR FIRST ORDER · CODE 1stOrder
Research hub

Protirelin TRH Peptide

Protirelin TRH is a synthetic tripeptide corresponding to thyrotropin-releasing hormone, studied in research on hypothalamic–pituitary signaling and neuroendocrine biology. Direct SARMs Spain supplies Protirelin TRH exclusively as laboratory research material. Browse the available products below:

Thyrotropin-releasing hormone (TRH)synthetic tripeptidepeptide hormonehypothalamic peptide
Molecular Weight
362.38 g/mol
Molecular Formula
C16H22N6O4
Purity
99.0%
Available nowProtirelin TRH Peptide · in stock, EU dispatch
Protirelin TRH Peptide Vial
20mg
Price range: $40.10 through $51.33View
01

What Is Protirelin TRH?

Protirelin TRH is the synthetic analogue of thyrotropin-releasing hormone (TRH), a naturally occurring tripeptide. It is composed of L-pyroglutamyl, L-histidyl, and L-prolinamide residues joined in sequence. This structure classifies Protirelin as a tripeptide and peptide hormone analogue.

Protirelin's defining chemical feature is its three-residue peptide structure commonly represented as pGlu-His-Pro-NH₂. Protirelin corresponds structurally to endogenous TRH and is therefore distinct from larger peptide or protein molecules. Its recognized molecular target is the thyrotropin-releasing hormone receptor (TRH-R), which belongs to the G-protein-coupled receptor family.

02

Research Overview Table

Research OverviewCurrent Status
Compound ClassSynthetic tripeptide hormone
Primary Research TargetThyrotropin-releasing hormone receptor (TRHR)
Published Cell StudiesAvailable
Published Animal StudiesAvailable
Controlled Human Clinical TrialsAvailable
Primary Research FieldEndocrinology, pituitary-thyroid axis, thyroid function, neuroendocrinology, and pituitary hormone research
Research MaturityEstablished preclinical and clinical research
Intended UseLaboratory research only
03

Chemical and Molecular Characteristics

Chemical NameL-pyroglutamyl-L-histidyl-L-prolinamide
Compound NameProtirelin (TRH)
Compound TypeSynthetic tripeptide hormone
Molecular FormulaC₁₆H₂₂N₆O₄
Molecular Weight362.38 g/mol
Purity99.0%
CAS Number24305-27-9
Batch/Lot NumberP260710-LR201030
Primary Research TargetThyrotropin-releasing hormone receptor (TRHR)
Product Format(s)Lyophilized vials, nasal sprays or pre-mixed injection pens
Physical PresentationSupplied as sterile lyophilized powder or pre-formulated liquid, depending on the selected product format

Protirelin TRH is a compact peptide molecule with a defined three-residue architecture. Its structure contains a pyroglutamyl N-terminus and a prolinamide C-terminus. Structural research has described TRH as adopting a folded, hairpin-like conformation stabilized by hydrogen bonding, rather than behaving as an extended peptide chain.

The molecule has a strongly polar physicochemical profile, with multiple hydrogen-bonding sites and low calculated lipophilicity. These characteristics arise from its peptide bonds, heteroatom-rich residues and terminal chemical groups. Compared with larger peptides and proteins. Protirelin has a much smaller molecular framework and limited conformational complexity.

Certificates:

CoAhttps://spain.direct-sarms.com/wp-content/uploads/2026/09/Protirelin-TRH_COA.pdf
HPLChttps://spain.direct-sarms.com/wp-content/uploads/2026/09/Protirelin-TRH_HPLC.pdf
04

Mechanism of Action Under Investigation

Protirelin corresponds to TRH and acts through the thyrotropin-releasing hormone receptor (TRH-R). Published studies show that TRH-R couples to Gq/G11 proteins, leading to activation of phospholipase C and phosphoinositide signaling.

Phospholipase C activation generates inositol 1,4,5-trisphosphate (IP3) and diacylglycerol. IP3 promotes intracellular calcium mobilization, while diacylglycerol contributes to protein kinase C activation. These events constitute the principal downstream signaling pathway described for TRH-R activation.

TRH-R activation also produces receptor phosphorylation and β-arrestin recruitment, which contribute to receptor desensitization and internalization. Studies further show that receptor internalization can occur without Gq/G11 coupling. indicating that receptor signaling and internalization are mechanistically separable processes.

05

Scientific Research Context

Protirelin TRH has a well-established scientific record spanning several decades. Investigations include laboratory experiments, animal research, and human studies. The literature developed from early work on TRH into research across multiple scientific settings. Despite the age of the literature, the evidence base remains weighted toward in vitro and preclinical animal research, while human investigations form a smaller portion of the published record.

06

Protirelin TRH Biology and Biological Pathways

01

Primary Biological Function

TRH is a hypothalamic neuropeptide involved in regulation of the hypothalamic-pituitary-thyroid axis. TRH-producing neurons in the paraventricular nucleus contribute to control of thyrotropin synthesis and release. TRH is also distributed within the central nervous system, where studies have identified additional neurobiological roles.

02

Relevant Metabolic or Signaling Pathways

TRH biology is closely connected with hypothalamic-pituitary-thyroid regulation and thyroid hormone feedback. Research has also examined relationships between TRH neurons, energy balance, nutritional status, and thyroid hormone availability. These pathways are investigated to understand how neuroendocrine regulation responds to changes in physiological state.

03

Tissue-Specific Biology

TRH is widely distributed in the central nervous system, with particularly high concentrations reported in the hypothalamic stalk-median eminence. Studies have also detected TRH in the pituitary, thyroid, brainstem, spinal cord, and several peripheral tissues. TRH receptor distribution likewise varies between tissues and cellular contexts.

04

Experimental Biomarkers

Research on TRH biology has examined TRH, TRH precursor-related peptides, thyrotropin (TSH), and thyroid hormones. TRH and precursor measurements provide information about peptide production and distribution, while TSH and thyroid hormone measurements reflect activity within the hypothalamic-pituitary-thyroid axis.

05

Laboratory Investigation Methods

Published studies have used radioimmunoassay, immunohistochemistry, autoradiography, tissue fractionation, and molecular approaches to investigate TRH distribution and related biology. These methods have been applied to characterize peptide localization, receptor distribution, tissue expression, and changes associated with thyroid-axis regulation.

07

Experimental Models Used in Published Research

Published Protirelin/TRH research includes cultured porcine thyroid cells, rat pituitary cell systems, rat hippocampal slices, and whole-rat models. These represent cellular, ex vivo tissue and whole-animal approaches. Their main limitations are the reduced physiological complexity of isolated systems and the species differences that limit direct extrapolation from animal models to human biology.

01

Porcine Thyroid-Cell Cultures

Published research has used cultured porcine thyroid cells as an in vitro model for Protirelin (TRH). The model is limited because cultured cells do not reproduce the full organization and regulation of an intact thyroid. Findings from porcine cells also have limited direct applicability to human thyroid biology because of species differences.

02

Rat Pituitary Cell Cultures

Primary rat pituitary cells and rat pituitary-derived cell lines have been used in Protirelin/TRH studies. These models provide isolated pituitary systems but do not reproduce the complete hypothalamic-pituitary axis. Cell-line models may also differ from normal pituitary cells in their phenotype and receptor characteristics.

03

Rat Hippocampal Slices

Rat hippocampal slices have been used as an ex vivo neural tissue model. The preparation preserves local tissue organization but removes normal systemic influences and long range neural connections. Findings from isolated rat hippocampal tissue therefore cannot be assumed to represent intact human brain physiology.

04

Rat Models

Whole-rat models have been used to investigate Protirelin/TRH in an intact physiological setting. Their principal limitation is species-specific biology, which can affect receptor distribution, metabolism and physiological responses. Consequently observations from rats cannot be directly extrapolated to humans without additional evidence.

08

Protirelin TRH Published Research

01

Thyroid-Axis Research

Researchers have investigated Protirelin TRH in relation to thyrotropin regulation, thyroid hormone responses and thyroid status. Studies have also examined the presence of TRH within the thyroid gland and its relationship with thyroid function.

02

Neuroendocrine Research

Published research has examined neuroendocrine responses to Protirelin TRH, including changes involving thyrotropin, prolactin, growth hormone, and other pituitary hormones.

03

Neurological Research

Researchers have investigated Protirelin TRH in relation to neurological function and neurological disorders, including cerebellar ataxia, upper motor neuron syndromes, amyotrophic lateral sclerosis, and cerebrovascular disorders.

04

Pharmacokinetic Research

Studies have investigated the pharmacokinetic and pharmacodynamic characteristics of Protirelin TRH, including circulating TRH concentrations and the relationship between Protirelin exposure and TSH responses.

09

Limitations of Current Research

01

Evidence Is Predominantly Preclinical

Protirelin has been investigated extensively, but a substantial part of the mechanistic literature comes from experimental research. This limits how confidently findings from laboratory and animal work can be extended to human biology. The evidence base therefore needs to be considered according to the specific research setting rather than as a single body of evidence.

02

Human Clinical Evidence

Human studies are available, including randomized and controlled investigations, but they differ in sample size, design, duration, and research purpose. Some studies included relatively small groups, while larger studies were open-label and lacked control groups. These differences limit direct comparison across the clinical literature.

03

Species Differences

Animal research forms an important part of the Protirelin literature, but findings from rats and other experimental species cannot be assumed to apply directly to humans. Differences in endocrine regulation and other physiological processes can affect how Protirelin-related responses translate between species.

04

Study Design Limitations

Published human investigations use different study designs, including randomized controlled trials, open studies, and retrospective analyses. Differences in participant selection, treatment protocols, controls, and follow-up make results difficult to compare directly. Retrospective studies also depend on existing clinical records rather than prospectively standardized research protocols.

05

Independent Replication

Replication is uneven across the different areas of Protirelin research. Some clinical questions have produced mixed findings, particularly in neurological research. Differences between studies in patient characteristics and experimental design make it difficult to determine whether conflicting observations reflect biological differences or methodological variation.

06

Long-Term Evidence

Long-term evidence remains limited in several areas. A 2026 retrospective study examined extended Protirelin treatment in spinocerebellar degeneration but specifically identified the need for prospective studies with standardized dosing and long-term follow-up. Earlier studies also included shorter treatment periods, leaving gaps in prospective long-duration evidence.

10

Analytical Documentation

HPLC can assess Protirelin TRH purity and separate related components. LC-MS can confirm molecular mass and support Protirelin TRH identity while also helping characterize related peptide species.

NMR can provide additional structural information when the peptide and analytical conditions allow reliable characterization. Researchers can use NMR alongside chromatography and mass spectrometry when additional structural evidence is required.

A Certificate of Analysis (CoA) records batch-specific analytical results, such as identity and purity. Analytical documentation verifies product identity and quality, not biological performance.

11

Storage and Laboratory Handling

Protirelin TRH from Direct Sarms Spain should be stored at 2–8°C according to the stated product specifications. The material should be handled by qualified laboratory personnel using appropriate laboratory procedures.

During handling, contamination should be prevented through suitable laboratory practices and by minimizing unnecessary exposure. Protirelin TRH should remain under the specified storage conditions and be used for laboratory research only.

12

Frequently asked questions

Protirelin TRH is a synthetic form of thyrotropin-releasing hormone (TRH), an endogenous tripeptide. It belongs to the thyrotropin-releasing hormone class and has been studied as a peptide signaling molecule in neuroendocrine and central nervous system research.
13

Why choose us?

Direct SARMs Spain is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.

Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.

Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs Spain, we aim to make the research supply process simple, clear, and reliable.

Protirelin TRH Peptide is supplied solely for laboratory research and analytical purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or any clinical application. Information provided on this page is for scientific reference only and should be considered alongside the cited primary literature and relevant analytical documentation.
Available now

Protirelin TRH Peptide from Direct Sarms Spain

Protirelin TRH Peptide Vial
20mg
Price range: $40.10 through $51.33View